Autologous monocyte-derived macrophage cell therapy (University of Edinburgh)

自体单核细胞衍生巨噬细胞（爱丁堡大学）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous monocyte-derived macrophage cell therapy (University of Edinburgh)

Drug Alias NameMonocyte-derived macrophage (University of Edinburgh)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Monocyte-derivedCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsFibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Edinburgh

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Edinburgh

Inactive CompaniesN/A

Active IndicationsFibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A